PsyMed Ventures Newsletter

Home
PsyMed Ventures Updates
Business Trip Episodes
Archive
About

Sitemap - 2021 - PsyMed Ventures Newsletter

MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy

On transformational ketamine therapy and running an integrative psychedelic clinic - Sage Integrative Health

The new frontiers of DMT therapies

Scaling psilocybin therapy: Compass Pathways' Lars Wilde

Ready for some psychedelic science?

Analyzing the atai Life Sciences IPO

A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx

👋Clubhouse: Understanding Psychedelic Medicine Startups

TOMORROW 👋Clubhouse: What’s new with Ketamine Psychotherapy

Founder of The Trip Report, Zach Haigney: Clinical trials, media, reciprocity, open science

Wednesday: 👋Clubhouse on Natural vs. Synthetic Psychedelic Medicine

How To (Legally) Make Psychedelic Medicine: CEO of Psygen, Danny Motyka

Tomorrow: 👋Clubhouse with Rick Doblin & Rachel Yehuda on MDMA-Assisted Therapy

NANA: From Serving Medicine to Company Founder

© 2025 PsyMed Ventures
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share